Sierra Oncology (SRRA) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2018-10-30 06:52:30

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (SRRA) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Finally, <b>Sofinnova Ventures</b> Inc acquired a new position in Sierra Oncology in the first quarter valued at approximately $203,000. 64.20% of the stock ...</div>

Article found on:

View Original Article